{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:22:36Z","timestamp":1790882556854,"version":"4.1.0"},"reference-count":322,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["675132"],"award-info":[{"award-number":["675132"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2634609"],"award-info":[{"award-number":["2634609"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.redox.2019.101119","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T12:24:36Z","timestamp":1551097476000},"page":"101119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"special_numbering":"C","title":["Lipoxidation in cardiovascular diseases"],"prefix":"10.1016","volume":"23","author":[{"given":"Erica","family":"Gianazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Brioschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma Martinez","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Banfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2019.101119_bib1","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.1074\/jbc.M116.762609","article-title":"Adductome-based identification of biomarkers for lipid peroxidation","volume":"292","author":"Shibata","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.redox.2019.101119_bib3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1021\/tx000101a","article-title":"Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation","volume":"13","author":"Lee","year":"2000","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.redox.2019.101119_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2012.08.565","article-title":"Lipidomics of oxidized polyunsaturated fatty acids","volume":"59","author":"Massey","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"Suppl 1","key":"10.1016\/j.redox.2019.101119_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/10715762.2013.815348","article-title":"Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation","volume":"47","author":"Vistoli","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2019.101119_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/572491","article-title":"Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases","volume":"2014","author":"Miller","year":"2014","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.redox.2019.101119_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cbi.2011.01.007","article-title":"Advanced lipoxidation end-products","volume":"192","author":"Pamplona","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.redox.2019.101119_bib8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3109\/10715762.2015.1040009","article-title":"Covalent modification of DNA by alpha, beta-unsaturated aldehydes derived from lipid peroxidation: recent progress and challenges","volume":"49","author":"Wei","year":"2015","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2019.101119_bib9","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.3390\/ijms14023285","article-title":"Non-enzymatic modification of aminophospholipids by carbonyl-amine reactions","volume":"14","author":"Naudi","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2019.101119_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jprot.2013.06.004","article-title":"Lipoxidation adducts with peptides and proteins: deleterious modifications or signaling mechanisms?","volume":"92","author":"Domingues","year":"2013","journal-title":"J. Proteom."},{"key":"10.1016\/j.redox.2019.101119_bib11","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/CIRCRESAHA.111.256859","article-title":"Role of phospholipid oxidation products in atherosclerosis","volume":"111","author":"Lee","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2019.101119_bib12","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1074\/jbc.271.17.9982","article-title":"The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions","volume":"271","author":"Fu","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.freeradbiomed.2016.10.497","article-title":"4-Hydroxynonenal (HNE) modified proteins in metabolic diseases","volume":"111","author":"Castro","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.redox.2013.01.006","article-title":"Lipofuscin: formation, effects and role of macroautophagy","volume":"1","author":"Hohn","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2019.101119_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0098-2997(03)00009-8","article-title":"Basic aspects of the biochemical reactivity of 4-hydroxynonenal","volume":"24","author":"Schaur","year":"2003","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.redox.2019.101119_bib16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/tx020105a","article-title":"Model studies on protein side chain modification by 4-oxo-2-nonenal","volume":"16","author":"Zhang","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.redox.2019.101119_bib17","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/tx3000818","article-title":"Quantitative analysis of acrolein-specific adducts generated during lipid peroxidation-modification of proteins in vitro: identification of N(tau)-(3-propanal)histidine as the major adduct","volume":"25","author":"Maeshima","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.redox.2019.101119_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.numecd.2005.05.003","article-title":"A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress","volume":"15","author":"Del Rio","year":"2005","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"issue":"Suppl","key":"10.1016\/j.redox.2019.101119_bib19","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1194\/jlr.R800037-JLR200","article-title":"Isoprostanes","volume":"50","author":"Roberts","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.redox.2019.101119_bib20","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","article-title":"A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism","volume":"87","author":"Morrow","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2019.101119_bib21","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.CIR.97.16.1536","article-title":"Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure","volume":"97","author":"Mallat","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2019.101119_bib22","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3109\/10715762.2015.1080363","article-title":"Levels of F2-isoprostanes, F4-neuroprostanes, and total nitrate\/nitrite in plasma and cerebrospinal fluid of patients with traumatic brain injury","volume":"49","author":"Yen","year":"2015","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2019.101119_bib23","first-page":"102","article-title":"Changes in levels of oxidative stress markers and some neuronal enzyme activities in cerebrospinal fluid of multiple sclerosis patients","volume":"37","author":"Bartova","year":"2016","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.redox.2019.101119_bib24","doi-asserted-by":"crossref","first-page":"10863","DOI":"10.1074\/jbc.274.16.10863","article-title":"Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway","volume":"274","author":"Chen","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1021\/tx034213o","article-title":"The cyclopentenone product of lipid peroxidation, 15-A2t-isoprostane, is efficiently metabolized by HepG2 cells via conjugation with glutathione","volume":"17","author":"Milne","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.redox.2019.101119_bib26","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbalip.2014.11.004","article-title":"Non-enzymatic cyclic oxygenated metabolites of adrenic, docosahexaenoic, eicosapentaenoic and alpha-linolenic acids; bioactivities and potential use as biomarkers","volume":"1851","author":"Galano","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2019.101119_bib27","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1194\/jlr.M700503-JLR200","article-title":"F2-dihomo-isoprostanes arise from free radical attack on adrenic acid","volume":"49","author":"VanRollins","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.redox.2019.101119_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1388-1981(00)00038-X","article-title":"Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway","volume":"1485","author":"Salomon","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2019.101119_bib29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/ars.2005.7.170","article-title":"New insights regarding the autoxidation of polyunsaturated fatty acids","volume":"7","author":"Yin","year":"2005","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2019.101119_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/ars.2005.7.202","article-title":"Isofurans: novel products of lipid peroxidation that define the occurrence of oxidant injury in settings of elevated oxygen tension","volume":"7","author":"Fessel","year":"2005","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2019.101119_bib31","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.bbadis.2007.04.009","article-title":"Oxidized phospholipids: from molecular properties to disease","volume":"1772","author":"Fruhwirth","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2019.101119_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.me.43.020192.001251","article-title":"The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis","volume":"43","author":"Parthasarathy","year":"1992","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.redox.2019.101119_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pathophys.2008.02.002","article-title":"Vascular endothelial function in health and diseases","volume":"15","author":"Khazaei","year":"2008","journal-title":"Pathophysiology"},{"key":"10.1016\/j.redox.2019.101119_bib34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/1874192401004010302","article-title":"The endothelium and its role in regulating vascular tone","volume":"4","author":"Sandoo","year":"2010","journal-title":"Open Cardiovasc. Med. J."},{"key":"10.1016\/j.redox.2019.101119_bib35","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3346\/jkms.2015.30.9.1213","article-title":"Endothelial dysfunction: clinical implications in cardiovascular disease and therapeutic approaches","volume":"30","author":"Park","year":"2015","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.redox.2019.101119_bib36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction: a marker of atherosclerotic risk","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.redox.2019.101119_bib37","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s00018-012-1194-z","article-title":"LOX-1 in atherosclerosis: biological functions and pharmacological modifiers","volume":"70","author":"Xu","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10557-011-6324-6","article-title":"The discovery of LOX-1, its ligands and clinical significance","volume":"25","author":"Yoshimoto","year":"2011","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.redox.2019.101119_bib39","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1440-1681.2009.05338.x","article-title":"High-density lipoprotein: a potent inhibitor of inflammation","volume":"37","author":"Murphy","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.redox.2019.101119_bib40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrd4279","article-title":"HDL-targeted therapies: progress, failures and future","volume":"13","author":"Kingwell","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.redox.2019.101119_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112315","article-title":"Oxidative stress in human atherothrombosis: sources, markers and therapeutic targets","volume":"18","author":"Martin-Ventura","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2019.101119_bib42","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbalip.2006.03.024","article-title":"Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid","volume":"1761","author":"Malle","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2019.101119_bib43","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1073\/pnas.77.4.2214","article-title":"Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages","volume":"77","author":"Fogelman","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2019.101119_bib44","first-page":"18","article-title":"The application of multiple reaction monitoring to assess Apo A-I methionine oxidations in diabetes and cardiovascular disease","volume":"4\u20135","author":"Yassine","year":"2014","journal-title":"Transl. Proteom."},{"key":"10.1016\/j.redox.2019.101119_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI4533","article-title":"Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins","volume":"103","author":"Horkko","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2019.101119_bib46","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41586-018-0198-8","article-title":"Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice","volume":"558","author":"Que","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.redox.2019.101119_bib47","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1021\/bi701659n","article-title":"Mechanism of 4-HNE mediated inhibition of hDDAH-1: implications in no regulation","volume":"47","author":"Forbes","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.redox.2019.101119_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/nu9070654","article-title":"N-3 polyunsaturated fatty acids decrease the protein expression of soluble epoxide hydrolase via oxidative stress-induced P38 kinase in rat endothelial cells","volume":"9","author":"Okada","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.redox.2019.101119_bib49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11883-010-0108-5","article-title":"Soluble epoxide hydrolase in atherosclerosis","volume":"12","author":"Wang","year":"2010","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.redox.2019.101119_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069415","article-title":"4-Hydroxy hexenal derived from docosahexaenoic acid protects endothelial cells via Nrf2 activation","volume":"8","author":"Ishikado","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2019.101119_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.freeradbiomed.2011.09.031","article-title":"Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis","volume":"52","author":"Leonarduzzi","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib52","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2337\/db07-1204","article-title":"Proinflammatory effects of advanced lipoxidation end products in monocytes","volume":"57","author":"Shanmugam","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2019.101119_bib53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.atherosclerosis.2010.11.018","article-title":"Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Kruppel-like factor 2","volume":"214","author":"van Tits","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.redox.2019.101119_bib54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.taap.2010.02.003","article-title":"Acrolein increases 5-lipoxygenase expression in murine macrophages through activation of ERK pathway","volume":"245","author":"Kim","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.redox.2019.101119_bib55","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.taap.2009.01.024","article-title":"Acrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophages","volume":"236","author":"O'Toole","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.redox.2019.101119_bib56","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/toxsci\/kfu233","article-title":"Molecular mechanisms of acrolein toxicity: relevance to human disease","volume":"143","author":"Moghe","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.redox.2019.101119_bib57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/cbf.3087","article-title":"Impact of 4-hydroxynonenal on matrix metalloproteinase-9 regulation in lipopolysaccharide-stimulated RAW 264.7 cells","volume":"33","author":"Schrimpe-Rutledge","year":"2015","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.redox.2019.101119_bib58","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.freeradbiomed.2008.08.022","article-title":"4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt\/NF-kappaB signaling pathways","volume":"45","author":"Lee","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib59","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbamcr.2006.06.003","article-title":"Acceleration of matrix metalloproteinase-1 production and activation of platelet-derived growth factor receptor beta in human coronary smooth muscle cells by oxidized LDL and 4-hydroxynonenal","volume":"1763","author":"Akiba","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2019.101119_bib60","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/ATVBAHA.113.300972","article-title":"4-Hydroxy-2-nonenal enhances tissue factor activity in human monocytic cells via p38 mitogen-activated protein kinase activation-dependent phosphatidylserine exposure","volume":"33","author":"Vatsyayan","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.redox.2019.101119_bib61","first-page":"29","article-title":"Age-related differential growth rate and response to 4-hydroxynonenal in mouse aortic smooth muscle cells","volume":"17","author":"Lee","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib62","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jacc.2017.05.035","article-title":"Impact of oxidative stress on the heart and vasculature: part 2 of a 3-part series","volume":"70","author":"Munzel","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.redox.2019.101119_bib63","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.ATV.0000139011.94634.9d","article-title":"Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins","volume":"24","author":"Guzik","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.redox.2019.101119_bib64","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/j.1538-7836.2005.01370.x","article-title":"New insights on oxidative stress in the artery wall","volume":"3","author":"Stocker","year":"2005","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.redox.2019.101119_bib65","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.redox.2014.12.008","article-title":"Elastin aging and lipid oxidation products in human aorta","volume":"4","author":"Zarkovic","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2019.101119_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-4682-9-11","article-title":"Neovascularization of coronary tunica intima (DIT) is the cause of coronary atherosclerosis. Lipoproteins invade coronary intima via neovascularization from adventitial vasa vasorum, but not from the arterial lumen: a hypothesis","volume":"9","author":"Subbotin","year":"2012","journal-title":"Theor. Biol. Med. Model."},{"key":"10.1016\/j.redox.2019.101119_bib67","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.freeradbiomed.2014.02.015","article-title":"4-Hydroxynonenal impairs transforming growth factor-beta1-induced elastin synthesis via epidermal growth factor receptor activation in human and murine fibroblasts","volume":"71","author":"Larroque-Cardoso","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib68","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.taap.2009.10.007","article-title":"4-Hydroxynonenal enhances MMP-9 production in murine macrophages via 5-lipoxygenase-mediated activation of ERK and p38 MAPK","volume":"242","author":"Lee","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.redox.2019.101119_bib69","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","article-title":"Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes","volume":"113","author":"Kolwicz","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2019.101119_bib70","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.redox.2019.101119_bib71","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/bph.12475","article-title":"Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy","volume":"171","author":"Fillmore","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2019.101119_bib72","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.RES.0000154079.20681.B9","article-title":"Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy","volume":"96","author":"Chiu","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2019.101119_bib73","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI0214080","article-title":"The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus","volume":"109","author":"Finck","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2019.101119_bib74","doi-asserted-by":"crossref","first-page":"22293","DOI":"10.1074\/jbc.M000248200","article-title":"Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity","volume":"275","author":"Watanabe","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib75","first-page":"3930","article-title":"Nuclear receptors PPARbeta\/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart","volume":"117","author":"Burkart","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2019.101119_bib76","doi-asserted-by":"crossref","first-page":"14145","DOI":"10.1074\/jbc.M500901200","article-title":"Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma","volume":"280","author":"Shiraki","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib77","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/nsmb.1474","article-title":"Structural basis for the activation of PPARgamma by oxidized fatty acids","volume":"15","author":"Itoh","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.redox.2019.101119_bib78","doi-asserted-by":"crossref","first-page":"35899","DOI":"10.1074\/jbc.M112.366419","article-title":"The peroxisome proliferator-activated receptor gamma (PPARgamma) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis","volume":"287","author":"Benedusi","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib79","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1161\/CIRCULATIONAHA.107.670588","article-title":"Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease","volume":"115","author":"Finck","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2019.101119_bib80","article-title":"Mitochondrial function in the heart: the insight into mechanisms and therapeutic potentials","author":"Nguyen","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2019.101119_bib81","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1440-1681.2011.05641.x","article-title":"Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart","volume":"39","author":"Anderson","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.redox.2019.101119_bib82","doi-asserted-by":"crossref","first-page":"C33","DOI":"10.1152\/ajpcell.00243.2006","article-title":"Role of cardiolipin alterations in mitochondrial dysfunction and disease","volume":"292","author":"Chicco","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.redox.2019.101119_bib83","doi-asserted-by":"crossref","first-page":"H3673","DOI":"10.1152\/ajpheart.00284.2007","article-title":"Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure","volume":"293","author":"Luo","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.redox.2019.101119_bib84","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/tox.21941","article-title":"alpha,beta-Unsaturated aldehyde pollutant acrolein suppresses cardiomyocyte contractile function: role of TRPV1 and oxidative stress","volume":"30","author":"Wu","year":"2015","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.redox.2019.101119_bib85","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1073\/pnas.97.2.611","article-title":"Modifications of proteins by polyunsaturated fatty acid peroxidation products","volume":"97","author":"Refsgaard","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2019.101119_bib86","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/toxsci\/kfl197","article-title":"Comet fluorescence in situ hybridization analysis for oxidative stress-induced DNA damage in colon cancer relevant genes","volume":"96","author":"Glei","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.redox.2019.101119_bib87","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1044-0305(99)00029-X","article-title":"Tandem mass spectrometry of model peptides modified with trans-2-hexenal, a product of lipid peroxidation","volume":"10","author":"Baker","year":"1999","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.redox.2019.101119_bib88","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1385\/CT:3:4:341","article-title":"Cardiac toxic effects of trans-2-hexenal are mediated by induction of cardiomyocyte apoptotic pathways","volume":"3","author":"Ping","year":"2003","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.redox.2019.101119_bib89","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0163-7827(03)00014-6","article-title":"4-Hydroxy-2-nonenal: a product and mediator of oxidative stress","volume":"42","author":"Uchida","year":"2003","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.redox.2019.101119_bib90","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.redox.2013.04.001","article-title":"Effects of 4-hydroxynonenal on vascular endothelial and smooth muscle cell redox signaling and function in health and disease","volume":"1","author":"Chapple","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2019.101119_bib91","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.yjmcc.2010.05.011","article-title":"4-hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway","volume":"49","author":"Zhang","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.redox.2019.101119_bib92","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.freeradbiomed.2015.03.032","article-title":"4-Hydroxynonenal induces Nrf2-mediated UCP3 upregulation in mouse cardiomyocytes","volume":"88","author":"Lopez-Bernardo","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib93","doi-asserted-by":"crossref","first-page":"864","DOI":"10.5114\/aoms.2016.63259","article-title":"Clinical importance of epicardial adipose tissue","volume":"13","author":"Nagy","year":"2017","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.redox.2019.101119_bib94","doi-asserted-by":"crossref","first-page":"E1703","DOI":"10.1152\/ajpendo.00462.2007","article-title":"Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative\/nitrative stress and differential regulation of eNOS\/iNOS activity","volume":"293","author":"Li","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.redox.2019.101119_bib95","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ahj.2007.03.019","article-title":"Human epicardial adipose tissue: a review","volume":"153","author":"Sacks","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.redox.2019.101119_bib96","doi-asserted-by":"crossref","first-page":"H202","DOI":"10.1152\/ajpheart.00120.2010","article-title":"Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress","volume":"299","author":"Salgado-Somoza","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.redox.2019.101119_bib97","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/954045","article-title":"The association between the epicardial adipose tissue thickness and oxidative stress parameters in isolated metabolic syndrome patients: a multimarker approach","volume":"2014","author":"Demir","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.redox.2019.101119_bib98","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.jacc.2011.02.038","article-title":"Adiposopathy is \"sick fat\" a cardiovascular disease?","volume":"57","author":"Bays","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.redox.2019.101119_bib99","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/oby.2003.3","article-title":"Adipose tissue quantification by imaging methods: a proposed classification","volume":"11","author":"Shen","year":"2003","journal-title":"Obes. Res."},{"key":"10.1016\/j.redox.2019.101119_bib100","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJMra1514009","article-title":"Mechanisms, pathophysiology, and management of obesity","volume":"376","author":"Heymsfield","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2019.101119_bib101","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature05487","article-title":"Mechanisms linking obesity with cardiovascular disease","volume":"444","author":"Van Gaal","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.redox.2019.101119_bib102","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.numecd.2006.07.005","article-title":"The link between abdominal obesity, metabolic syndrome and cardiovascular disease","volume":"17","author":"Ritchie","year":"2007","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.redox.2019.101119_bib103","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2019.101119_bib104","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.freeradbiomed.2004.12.010","article-title":"Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes","volume":"38","author":"Soares","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib105","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.biochi.2012.12.014","article-title":"Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance","volume":"95","author":"Murdolo","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.redox.2019.101119_bib106","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1021\/bi702124u","article-title":"Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice","volume":"47","author":"Singh","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.redox.2019.101119_bib107","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1074\/mcp.M600120-MCP200","article-title":"Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal","volume":"6","author":"Grimsrud","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.redox.2019.101119_bib108","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.biochi.2004.10.018","article-title":"The role of MAPKs in adipocyte differentiation and obesity","volume":"87","author":"Bost","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.redox.2019.101119_bib109","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2017.01.015","article-title":"4-hydroxynonenal causes impairment of human subcutaneous adipogenesis and induction of adipocyte insulin resistance","volume":"104","author":"Elrayess","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib110","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1093\/emboj\/cdg412","article-title":"A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling","volume":"22","author":"Echtay","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.redox.2019.101119_bib111","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bbadis.2015.01.015","article-title":"On the role of 4-hydroxynonenal in health and disease","volume":"1852","author":"Csala","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2019.101119_bib112","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.bjp.0707395","article-title":"Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors","volume":"153","author":"Negre-Salvayre","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2019.101119_bib113","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2008.04.007","article-title":"Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death","volume":"45","author":"Awasthi","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib114","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1089\/ars.2014.6098","article-title":"Oxidative lipidomics coming of age: advances in analysis of oxidized phospholipids in physiology and pathology","volume":"22","author":"Spickett","year":"2015","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2019.101119_bib115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.freeradbiomed.2017.02.035","article-title":"The effect of oxidized phospholipids on phenotypic polarization and function of macrophages","volume":"111","author":"Serbulea","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib116","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.mrfmmm.2003.07.008","article-title":"Enzymology of repair of etheno-adducts","volume":"531","author":"Gros","year":"2003","journal-title":"Mutat. Res."},{"key":"10.1016\/j.redox.2019.101119_bib117","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1050-1738(01)00094-9","article-title":"Oxidative DNA damage and cardiovascular disease","volume":"11","author":"Lee","year":"2001","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.redox.2019.101119_bib118","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mrfmmm.2007.02.013","article-title":"Lipid peroxidation-derived etheno-DNA adducts in human atherosclerotic lesions","volume":"621","author":"Nair","year":"2007","journal-title":"Mutat. Res."},{"key":"10.1016\/j.redox.2019.101119_bib119","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.3390\/biom5042247","article-title":"4-Hydroxy-nonenal-A bioactive lipid peroxidation product","volume":"5","author":"Schaur","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.redox.2019.101119_bib120","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.redox.2019.101119_bib121","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/47520","article-title":"Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase","volume":"403","author":"Rossi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.redox.2019.101119_bib122","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1073\/pnas.97.9.4844","article-title":"15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway","volume":"97","author":"Straus","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2019.101119_bib123","doi-asserted-by":"crossref","first-page":"35530","DOI":"10.1074\/jbc.M104518200","article-title":"15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit","volume":"276","author":"Cernuda-Morollon","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib124","first-page":"1660","article-title":"[Activation mechanism of PPARgamma by its endogenous ligands]","volume":"50","author":"Shiraki","year":"2005","journal-title":"Tanpakushitsu Kakusan Koso"},{"key":"10.1016\/j.redox.2019.101119_bib125","first-page":"140","article-title":"Update: systemic diseases and the cardiovascular system (i): obesity and the heart","volume":"64","author":"Lopez-Jimenez","year":"2011","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.redox.2019.101119_bib126","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1089\/ars.2007.1595","article-title":"Mechanisms for oxidative stress in diabetic cardiovascular disease","volume":"9","author":"Pennathur","year":"2007","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2019.101119_bib127","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.exger.2009.07.003","article-title":"Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders","volume":"44","author":"Mattson","year":"2009","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.redox.2019.101119_bib128","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.ijo.0801536","article-title":"Mechanism for obesity-induced increase in myocardial lipid peroxidation","volume":"25","author":"Vincent","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.redox.2019.101119_bib129","article-title":"Increased 4-hydroxynonenal formation contributes to obesity-related lipolytic activation in adipocytes","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2019.101119_bib130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0026-0495(97)90311-5","article-title":"Glycation, oxidation, and lipoxidation in the development of diabetic complications","volume":"46","author":"Kennedy","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.redox.2019.101119_bib131","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/diab.34.9.938","article-title":"Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein","volume":"34","author":"Brownlee","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2019.101119_bib132","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0008-6363(00)00118-8","article-title":"Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm","volume":"47","author":"Mezzetti","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.redox.2019.101119_bib133","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1073\/pnas.91.20.9441","article-title":"Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency","volume":"91","author":"Bucala","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2019.101119_bib134","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.abb.2018.03.026","article-title":"A mass spectrometry approach for the identification and localization of small aldehyde modifications of proteins","volume":"646","author":"Afonso","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.redox.2019.101119_bib135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ab.2016.10.021","article-title":"Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges","volume":"524","author":"Tsikas","year":"2017","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.redox.2019.101119_bib136","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.redox.2013.01.007","article-title":"The lipid peroxidation product 4-hydroxy-2-nonenal: advances in chemistry and analysis","volume":"1","author":"Spickett","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2019.101119_bib137","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.redox.2014.01.016","article-title":"High throughput assay for evaluation of reactive carbonyl scavenging capacity","volume":"2","author":"Vidal","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2019.101119_bib138","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jchromb.2010.08.004","article-title":"Chemical probes for analysis of carbonylated proteins: a review","volume":"879","author":"Yan","year":"2011","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib139","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3109\/10715762.2015.1059936","article-title":"Oxidative stress: determination of 4-hydroxy-2-nonenal by gas chromatography\/mass spectrometry in human and rat plasma","volume":"49","author":"Zelzer","year":"2015","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2019.101119_bib140","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/oxfordjournals.jbchem.a022025","article-title":"Validation of malondialdehyde and 4-hydroxy-2-trans-nonenal measurement in plasma by NICI-GC-MS","volume":"123","author":"Rauli","year":"1998","journal-title":"J. Biochem."},{"key":"10.1016\/j.redox.2019.101119_bib141","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1570-0232(02)00242-8","article-title":"Measurement of 4-hydroxynonenal in small volume blood plasma samples: modification of a gas chromatographic-mass spectrometric method for clinical settings","volume":"774","author":"Spies-Martin","year":"2002","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib142","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/rcm.7577","article-title":"Identification of 4-hydroxynonenal protein targets in rat, mouse and human liver microsomes by two-dimensional liquid chromatography\/tandem mass spectrometry","volume":"30","author":"Golizeh","year":"2016","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.redox.2019.101119_bib143","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/(SICI)1097-0231(19990815)13:15<1573::AID-RCM675>3.0.CO;2-Z","article-title":"Determination of 4-hydroxy-2-nonenal at cellular levels by means of electrospray mass spectrometry","volume":"13","author":"Gioacchini","year":"1999","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.redox.2019.101119_bib144","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jprot.2013.03.030","article-title":"Mass spectrometric approaches for the identification and quantification of reactive carbonyl species protein adducts","volume":"92","author":"Colzani","year":"2013","journal-title":"J. Proteom."},{"key":"10.1016\/j.redox.2019.101119_bib145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mas.10076","article-title":"Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins","volume":"23","author":"Carini","year":"2004","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.redox.2019.101119_bib146","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.freeradbiomed.2016.12.009","article-title":"Contribution of the HNE-immunohistochemistry to modern pathological concepts of major human diseases","volume":"111","author":"Zarkovic","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib147","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/10715760600693422","article-title":"Enzyme-linked immunosorbent assay for 4-hydroxynonenal-histidine conjugates","volume":"40","author":"Borovic","year":"2006","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2019.101119_bib148","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/01.ATV.10.3.325","article-title":"Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein","volume":"10","author":"Palinski","year":"1990","journal-title":"Arteriosclerosis"},{"issue":"Pt 1","key":"10.1016\/j.redox.2019.101119_bib149","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj2880249","article-title":"Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination","volume":"288","author":"Chen","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.redox.2019.101119_bib150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/abbi.1995.0036","article-title":"Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies","volume":"324","author":"Uchida","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.redox.2019.101119_bib151","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-5793(00)01539-8","article-title":"Detection of lipofuscin-like fluorophore in oxidized human low-density lipoprotein. 4-hydroxy-2-nonenal as a potential source of fluorescent chromophore","volume":"473","author":"Itakura","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.redox.2019.101119_bib152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2011.02.037","article-title":"A method for detection of 4-hydroxy-2-nonenal adducts in proteins","volume":"51","author":"Wakita","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib153","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11596-015-1411-8","article-title":"Oxidized LDL stimulates lipid peroxidation-derived DNA and protein adducts in human vascular endothelial and smooth muscle cells","volume":"35","author":"Liu","year":"2015","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.redox.2019.101119_bib154","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/296146","article-title":"Generation of adducts of 4-Hydroxy-2-nonenal with heat shock 60 kDa protein 1 in human promyelocytic HL-60 and monocytic THP-1 cell lines","volume":"2015","author":"Arcaro","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.redox.2019.101119_bib155","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1073\/pnas.90.18.8742","article-title":"Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes","volume":"90","author":"Uchida","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2019.101119_bib156","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.redox.2013.01.012","article-title":"Measurement of HNE-protein adducts in human plasma and serum by ELISA-Comparison of two primary antibodies","volume":"1","author":"Weber","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2019.101119_bib157","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1021\/tx025590o","article-title":"Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal","volume":"15","author":"Doorn","year":"2002","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.redox.2019.101119_bib158","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1021\/tx700347w","article-title":"Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives","volume":"21","author":"Vila","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.redox.2019.101119_bib159","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jms.1978","article-title":"Isotope-coded dimethyl tagging for differential quantification of posttranslational protein carbonylation by 4-hydroxy-2-nonenal, an end-product of lipid peroxidation","volume":"46","author":"Rauniyar","year":"2011","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.redox.2019.101119_bib160","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jprot.2011.03.031","article-title":"Site-specific proteomic analysis of lipoxidation adducts in cardiac mitochondria reveals chemical diversity of 2-alkenal adduction","volume":"74","author":"Chavez","year":"2011","journal-title":"J. Proteom."},{"key":"10.1016\/j.redox.2019.101119_bib161","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fphys.2015.00098","article-title":"Two dimensional blue native\/SDS-PAGE to identify mitochondrial complex I subunits modified by 4-hydroxynonenal (HNE)","volume":"6","author":"Wu","year":"2015","journal-title":"Front. Physiol."},{"key":"10.1016\/j.redox.2019.101119_bib162","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.biocel.2016.08.001","article-title":"Proteomic analysis of 4-hydroxynonenal and nitrotyrosine modified proteins in RTT fibroblasts","volume":"81","author":"Pecorelli","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.redox.2019.101119_bib163","first-page":"A12949","article-title":"Abstract 12949: elamipretide (BendaviaTM) restores 4-hydroxy-2-nonenal protein adducts and aldehyde dehydrogenase-2 activity and mRNA expression in left ventricular myocardium of dogs with advanced heart failure","volume":"134","author":"Gupta","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2019.101119_bib164","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/cvr\/cvu125","article-title":"Aldehyde dehydrogenase 2 activation in heart failure restores mitochondrial function and improves ventricular function and remodelling","volume":"103","author":"Gomes","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.redox.2019.101119_bib165","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1161\/01.CIR.0000018605.14470.DD","article-title":"Carvedilol decreases elevated oxidative stress in human failing myocardium","volume":"105","author":"Nakamura","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2019.101119_bib166","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1071-9164(00)90012-5","article-title":"Unsaturated aldehydes including 4-OH-nonenal are elevated in patients with congestive heart failure","volume":"6","author":"Mak","year":"2000","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.redox.2019.101119_bib167","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10337-012-2237-1","article-title":"Recent advancements in the LC- and GC-based analysis of malondialdehyde (MDA): a brief overview","volume":"75","author":"Giera","year":"2012","journal-title":"Chromatographia"},{"key":"10.1016\/j.redox.2019.101119_bib168","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0006-2944(76)90049-1","article-title":"A simple fluorometric assay for lipoperoxide in blood plasma","volume":"15","author":"Yagi","year":"1976","journal-title":"Biochem. Med."},{"key":"10.1016\/j.redox.2019.101119_bib169","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/clinchem\/34.12.2433","article-title":"Specificity of the thiobarbituric acid reaction: its use in studies of lipid peroxidation","volume":"34","author":"Knight","year":"1988","journal-title":"Clin. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib170","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/elps.201100143","article-title":"Detection of malondialdehyde in vivo using microdialysis sampling with CE-fluorescence","volume":"32","author":"Cooley","year":"2011","journal-title":"Electrophoresis"},{"key":"10.1016\/j.redox.2019.101119_bib171","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1570-0232(02)00273-8","article-title":"Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples","volume":"775","author":"Agarwal","year":"2002","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib172","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1373\/49.4.690","article-title":"Rapid fluorimetric method to detect total plasma malondialdehyde with mild derivatization conditions","volume":"49","author":"Del Rio","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib173","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2116\/analsci.19.621","article-title":"Determination of thiobarbituric acid adduct of malondialdehyde using on-line microdialysis coupled with high-performance liquid chromatography","volume":"19","author":"Sheu","year":"2003","journal-title":"Anal. Sci."},{"key":"10.1016\/j.redox.2019.101119_bib174","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.talanta.2009.01.044","article-title":"Automated on-line microdialysis sampling coupled with high-performance liquid chromatography for simultaneous determination of malondialdehyde and ofloxacin in whole blood","volume":"79","author":"Cheng","year":"2009","journal-title":"Talanta"},{"key":"10.1016\/j.redox.2019.101119_bib175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jchromb.2015.10.009","volume":"1019","author":"Tsikas","year":"2016","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib176","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0378-4347(00)00174-2","article-title":"Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative","volume":"742","author":"Pilz","year":"2000","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.redox.2019.101119_bib177","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1570-0232(03)00495-1","article-title":"Measurement by reversed-phase high-performance liquid chromatography of malondialdehyde in normal human urine following derivatisation with 2,4-dinitrophenylhydrazine","volume":"794","author":"Korchazhkina","year":"2003","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib178","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3109\/10715762.2013.812205","article-title":"Measurement of total and free malondialdehyde by gas-chromatography mass spectrometry--comparison with high-performance liquid chromatography methology","volume":"47","author":"Zelzer","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2019.101119_bib179","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jchromb.2018.05.001","article-title":"Analysis of malondialdehyde in human plasma samples through derivatization with 2,4-dinitrophenylhydrazine by ultrasound-assisted dispersive liquid-liquid microextraction-GC-FID approach","volume":"1089","author":"Malaei","year":"2018","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchromb.2005.12.041","article-title":"New method for HPLC separation and fluorescence detection of malonaldehyde in normal human plasma","volume":"832","author":"Mao","year":"2006","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib181","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jchromb.2008.12.035","article-title":"Determination of malondialdehyde in human plasma by fully automated solid phase analytical derivatization","volume":"877","author":"Lord","year":"2009","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib182","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1021\/tx9701790","article-title":"Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation","volume":"11","author":"Gerard-Monnier","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.redox.2019.101119_bib183","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2203\/dose-response.10-002.Siddique","article-title":"Estimation of lipid peroxidation induced by hydrogen peroxide in cultured human lymphocytes","volume":"10","author":"Siddique","year":"2012","journal-title":"Dose Response"},{"key":"10.1016\/j.redox.2019.101119_bib184","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0891-5849(01)00578-0","article-title":"Diaminonaphtalene, a new highly specific reagent for HPLC-UV measurement of total and free malondialdehyde in human plasma or serum","volume":"31","author":"Steghens","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib185","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1039\/c1an15254h","article-title":"Mild and selective labeling of malondialdehyde with 2-aminoacridone: assessment of urinary malondialdehyde levels","volume":"136","author":"Giera","year":"2011","journal-title":"Analyst"},{"key":"10.1016\/j.redox.2019.101119_bib186","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.jchromb.2010.02.010","article-title":"Evaluation of Alternate Isotope-Coded Derivatization Assay (AIDA) in the LC-MS\/MS analysis of aldehydes in exhaled breath condensate","volume":"878","author":"Manini","year":"2010","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib187","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1016\/j.jchromb.2009.09.043","article-title":"Development of an on-line weak-cation exchange liquid chromatography-tandem mass spectrometric method for screening aldehyde products in biological matrices","volume":"877","author":"Eggink","year":"2009","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib188","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1039\/C5AN00657K","article-title":"Profiling of aldehyde-containing compounds by stable isotope labelling-assisted mass spectrometry analysis","volume":"140","author":"Yu","year":"2015","journal-title":"Analyst"},{"key":"10.1016\/j.redox.2019.101119_bib189","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jchromb.2003.08.004","article-title":"Improved procedure for the determination of malonaldehyde by gas-chromatography with electron-capture detection as 2,4,6-trichlorophenylhydrazine derivative","volume":"796","author":"Sangalli","year":"2003","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib190","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1016\/j.jchromb.2009.09.022","article-title":"Determination of malondialdehyde in human blood by headspace-solid phase micro-extraction gas chromatography-mass spectrometry after derivatization with 2,2,2-trifluoroethylhydrazine","volume":"877","author":"Shin","year":"2009","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib191","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clinbiochem.2009.10.002","article-title":"Human plasma concentrations of malondialdehyde (MDA) and the F2-isoprostane 15(S)-8-iso-PGF(2alpha) may be markedly compromised by hemolysis: evidence by GC-MS\/MS and potential analytical and biological ramifications","volume":"43","author":"Dreissigacker","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.redox.2019.101119_bib192","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0003-2697(02)00387-1","article-title":"Determination of free malondialdehyde in human serum by high-performance liquid chromatography","volume":"311","author":"Karatas","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.redox.2019.101119_bib193","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/elps.201100056","article-title":"Field-amplified online sample stacking capillary electrophoresis UV detection for plasma malondialdehyde measurement","volume":"32","author":"Zinellu","year":"2011","journal-title":"Electrophoresis"},{"key":"10.1016\/j.redox.2019.101119_bib194","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.jchromb.2009.06.008","article-title":"Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases","volume":"877","author":"Syslova","year":"2009","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib195","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jchromb.2016.07.013","article-title":"Development and evaluation of a liquid chromatography-mass spectrometry method for rapid, accurate quantitation of malondialdehyde in human plasma","volume":"1029\u20131030","author":"Sobsey","year":"2016","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib196","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ab.2016.08.009","article-title":"Simultaneous GC-MS\/MS measurement of malondialdehyde and 4-hydroxy-2-nonenal in human plasma: effects of long-term L-arginine administration","volume":"524","author":"Tsikas","year":"2017","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.redox.2019.101119_bib197","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/sj.bjp.0705384","article-title":"Malondialdehyde inhibits cardiac contractile function in ventricular myocytes via a p38 mitogen-activated protein kinase-dependent mechanism","volume":"139","author":"Folden","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2019.101119_bib198","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0002-8703(96)90063-0","article-title":"Increased malondialdehyde in peripheral blood of patients with congestive heart failure","volume":"131","author":"Diaz-Velez","year":"1996","journal-title":"Am. Heart J."},{"key":"10.1016\/j.redox.2019.101119_bib199","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/hrt.65.5.245","article-title":"Oxygen free radicals and congestive heart failure","volume":"65","author":"Belch","year":"1991","journal-title":"Br. Heart J."},{"key":"10.1016\/j.redox.2019.101119_bib200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1527-5299.2001.00261.x","article-title":"Relation of functional capacity with the oxidative stress and antioxidants in chronic heart failure","volume":"7","author":"Serdar","year":"2001","journal-title":"Congest. Heart Fail."},{"key":"10.1016\/j.redox.2019.101119_bib201","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cardfail.2012.04.003","article-title":"Markers of oxidative damage and antioxidant enzyme activities as predictors of morbidity and mortality in patients with chronic heart failure","volume":"18","author":"Radovanovic","year":"2012","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.redox.2019.101119_bib202","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1021\/ac60267a019","article-title":"Fluorometric determination of acrolein and related compounds with m-aminophenol","volume":"40","author":"Alarcon","year":"1968","journal-title":"Anal. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib203","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0378-4347(96)00457-4","article-title":"High-performance liquid chromatographic determination of acrolein as a marker for cyclophosphamide bioactivation in human liver microsomes","volume":"692","author":"Bohnenstengel","year":"1997","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.redox.2019.101119_bib204","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1021\/ol1002219","article-title":"Sensitive detection of acrolein in serum using time-resolved luminescence","volume":"12","author":"Togashi","year":"2010","journal-title":"Org. Lett."},{"key":"10.1016\/j.redox.2019.101119_bib205","doi-asserted-by":"crossref","first-page":"14946","DOI":"10.1039\/C4CC02578D","article-title":"Practical fluorescence detection of acrolein in human plasma via a two-step tethering approach","volume":"50","author":"Togashi","year":"2014","journal-title":"Chem Commun (Camb)."},{"key":"10.1016\/j.redox.2019.101119_bib206","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ab.2014.07.002","article-title":"Analytical method for lipoperoxidation relevant reactive aldehydes in human sera by high-performance liquid chromatography-fluorescence detection","volume":"464","author":"El-Maghrabey","year":"2014","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.redox.2019.101119_bib207","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0378-4347(99)00485-5","article-title":"Quantitative high-performance liquid chromatographic determination of acrolein in plasma after derivatization with Luminarin 3","volume":"739","author":"Paci","year":"2000","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.redox.2019.101119_bib208","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/bmc.3422","article-title":"Determination of acrolein in serum by high-performance liquid chromatography with fluorescence detection after pre-column fluorogenic derivatization using 1,2-diamino-4,5-dimethoxybenzene","volume":"29","author":"Imazato","year":"2015","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.redox.2019.101119_bib209","doi-asserted-by":"crossref","first-page":"16058","DOI":"10.1074\/jbc.273.26.16058","article-title":"Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins","volume":"273","author":"Uchida","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib210","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1021\/tx3004104","article-title":"Detection of acrolein-derived cyclic DNA adducts in human cells by monoclonal antibodies","volume":"25","author":"Pan","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.redox.2019.101119_bib211","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/15287390490276539","article-title":"Quantitation of acrolein-protein adducts: potential biomarker of acrolein exposure","volume":"67","author":"Li","year":"2004","journal-title":"J. Toxicol. Environ. Health"},{"key":"10.1016\/j.redox.2019.101119_bib212","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.freeradbiomed.2010.02.016","article-title":"Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease","volume":"48","author":"Bradley","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib213","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/rcm.960","article-title":"Determination of patterns of biologically relevant aldehydes in exhaled breath condensate of healthy subjects by liquid chromatography\/atmospheric chemical ionization tandem mass spectrometry","volume":"17","author":"Andreoli","year":"2003","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.redox.2019.101119_bib214","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1016\/j.chroma.2010.04.056","article-title":"Determination of acrolein and other carbonyls in cigarette smoke using coupled silica cartridges impregnated with hydroquinone and 2,4-dinitrophenylhydrazine","volume":"1217","author":"Uchiyama","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.redox.2019.101119_bib215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.chroma.2004.11.098","article-title":"Determination of aliphatic aldehydes by liquid chromatography with pulsed amperometric detection","volume":"1063","author":"Casella","year":"2005","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.redox.2019.101119_bib216","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/mnfr.201100255","article-title":"Mass spectrometry-based quantification of myocardial protein adducts with acrolein in an in vivo model of oxidative stress","volume":"55","author":"Wu","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.redox.2019.101119_bib217","first-page":"300","article-title":"Methods for estimating lipid peroxidation: an analysis of merits and demerits","volume":"40","author":"Devasagayam","year":"2003","journal-title":"Indian J. Biochem. Biophys."},{"key":"10.1016\/j.redox.2019.101119_bib218","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/rcm.4871","article-title":"Quantification of 15-F2t-isoprostane in human plasma and urine: results from enzyme-linked immunoassay and liquid chromatography\/tandem mass spectrometry cannot be compared","volume":"25","author":"Klawitter","year":"2011","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.redox.2019.101119_bib219","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpba.2013.11.028","article-title":"Optimized method for quantification of total F(2)-isoprostanes using gas chromatography-tandem mass spectrometry","volume":"90","author":"Briskey","year":"2014","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.redox.2019.101119_bib220","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbalip.2014.10.007","article-title":"The isoprostanes--25 years later","volume":"1851","author":"Milne","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2019.101119_bib221","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ab.2013.12.030","article-title":"Minimizing artifactual elevation of lipid peroxidation products (F2-isoprostanes) in plasma during collection and storage","volume":"449","author":"Barden","year":"2014","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.redox.2019.101119_bib222","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/ars.2009.2934","article-title":"Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues","volume":"13","author":"Halliwell","year":"2010","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2019.101119_bib223","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5603\/ARM.2018.0002","article-title":"Concentration of 8-isoprostanes in the exhaled breath condensate as a marker of oxidative stress in patients with type 1 diabetes","volume":"86","author":"Pekala-Wojciechowska","year":"2018","journal-title":"Adv. Respir. Med."},{"key":"10.1016\/j.redox.2019.101119_bib224","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5405847","article-title":"The oxidative and inflammatory state in patients with acute renal graft dysfunction treated with tacrolimus","volume":"2016","author":"Carrillo-Ibarra","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.redox.2019.101119_bib225","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jpba.2009.06.015","article-title":"Development of enzyme-linked immunosorbent assay for 8-iso-prostaglandin F2alpha, a biomarker of oxidative stress in vivo, and its application to the quantification in aged rats","volume":"50","author":"Chu","year":"2009","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.redox.2019.101119_bib226","first-page":"3","article-title":"(2)-isoprostanes: sensitive biomarkers of oxidative stress in vitro and in vivo: a gas chromatography-mass spectrometric approach","volume":"580","author":"Wiswedel","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.redox.2019.101119_bib227","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2012.09.030","article-title":"Measurement of F2- isoprostanes and isofurans using gas chromatography-mass spectrometry","volume":"59","author":"Milne","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib228","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ab.2009.10.014","article-title":"Simultaneous quantification of 8-iso-prostaglandin-F(2alpha) and 11-dehydro thromboxane B(2) in human urine by liquid chromatography-tandem mass spectrometry","volume":"397","author":"Cavalca","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.redox.2019.101119_bib229","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/HYPERTENSIONAHA.112.199315","article-title":"Assessment of urinary F(2)-isoprostanes in experimental and clinical studies: mass spectrometry versus ELISA","volume":"60","author":"Tsikas","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.redox.2019.101119_bib230","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1021\/jf101146q","article-title":"Determination of F2-isoprostanes in urine by online solid phase extraction coupled to liquid chromatography with tandem mass spectrometry","volume":"58","author":"Langhorst","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.redox.2019.101119_bib231","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11745-013-3767-5","article-title":"A fast one-step extraction and UPLC-MS\/MS analysis for E2\/D 2 series prostaglandins and isoprostanes","volume":"48","author":"Brose","year":"2013","journal-title":"Lipids"},{"key":"10.1016\/j.redox.2019.101119_bib232","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jchromb.2014.12.019","article-title":"Protocols for the measurement of the F2-isoprostane, 15(S)-8-iso-prostaglandin F2alpha, in biological samples by GC-MS or GC-MS\/MS coupled with immunoaffinity column chromatography","volume":"1019","author":"Tsikas","year":"2016","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib233","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.freeradbiomed.2009.07.028","article-title":"Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method","volume":"47","author":"Liu","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib234","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0003-2697(02)00392-5","article-title":"Derivatization of F2-isoprostanes with 1-pyrenyldiazomethane and their subsequent determination by fluorescence high-performance liquid chromatography","volume":"311","author":"Ritov","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.redox.2019.101119_bib235","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.talanta.2010.03.009","article-title":"Quantification of F(2)-isoprostane isomers in cultured human lung epithelial cells after silica oxide and metal oxide nanoparticle treatment by liquid chromatography\/tandem mass spectrometry","volume":"81","author":"Liu","year":"2010","journal-title":"Talanta"},{"key":"10.1016\/j.redox.2019.101119_bib236","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ab.2009.09.042","article-title":"Quantitation of plasma total 15-series F(2)-isoprostanes by sequential solid phase and liquid-liquid extraction","volume":"396","author":"Taylor","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.redox.2019.101119_bib237","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s11745-016-4198-x","article-title":"Assessment of isoprostanes in human plasma: technical considerations and the use of mass spectrometry","volume":"51","author":"Lee","year":"2016","journal-title":"Lipids"},{"key":"10.1016\/j.redox.2019.101119_bib238","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s11745-008-3222-1","article-title":"Women and smokers have elevated urinary F(2)-isoprostane metabolites: a novel extraction and LC-MS methodology","volume":"43","author":"Taylor","year":"2008","journal-title":"Lipids"},{"key":"10.1016\/j.redox.2019.101119_bib239","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jchromb.2014.06.021","article-title":"Matrix effect in F(2)-isoprostanes quantification by HPLC-MS\/MS: a validated method for analysis of iPF(2)alpha-III and iPF(2)alpha-VI in human urine","volume":"965","author":"Petrosino","year":"2014","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"issue":"19","key":"10.1016\/j.redox.2019.101119_bib240","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/rcm.8224","article-title":"Development of a method for the determination of 8-iso-PGF2alpha in sheep and goat plasma using solid phase micro-extraction and UPLC-MS\/MS","volume":"32","author":"Rodr\u00edguez Pati\u00f1o","year":"2018","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.redox.2019.101119_bib241","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.freeradbiomed.2011.07.001","article-title":"LC\/ESR\/MS study of pH-dependent radical generation from 15-LOX-catalyzed DPA peroxidation","volume":"51","author":"Purwaha","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib242","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-5793(00)01587-8","article-title":"A novel fluorescent probe diphenyl-1-pyrenylphosphine to follow lipid peroxidation in cell membranes","volume":"474","author":"Okimotoa","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.redox.2019.101119_bib243","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0891-5849(02)01435-1","article-title":"Fluorescence imaging of lipid peroxidation in isolated rat lungs during nonhypoxic lung ischemia","volume":"34","author":"Matot","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib244","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1021\/ac100280p","article-title":"Analysis of oxidized phospholipids by MALDI mass spectrometry using 6-aza-2-thiothymine together with matrix additives and disposable target surfaces","volume":"82","author":"Stubiger","year":"2010","journal-title":"Anal. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib245","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.chemphyslip.2012.06.001","article-title":"Mapping of phospholipids by MALDI imaging (MALDI-MSI): realities and expectations","volume":"165","author":"Sparvero","year":"2012","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.redox.2019.101119_bib246","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.atherosclerosis.2012.06.010","article-title":"Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS\/MS","volume":"224","author":"Stubiger","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.redox.2019.101119_bib247","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.freeradbiomed.2017.11.012","article-title":"Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids","volume":"115","author":"Gao","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib248","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.freeradbiomed.2016.12.034","article-title":"Pleiotropic effects of oxidized phospholipids","volume":"111","author":"Bochkov","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib249","doi-asserted-by":"crossref","first-page":"15138","DOI":"10.1038\/s41598-017-15363-z","article-title":"LPPtiger software for lipidome-specific prediction and identification of oxidized phospholipids from LC-MS datasets","volume":"7","author":"Ni","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2019.101119_bib250","doi-asserted-by":"crossref","first-page":"8376","DOI":"10.1021\/ac401778f","article-title":"Gold nanoparticle-conjugated anti-oxidized low-density lipoprotein antibodies for targeted lipidomics of oxidative stress biomarkers","volume":"85","author":"Hinterwirth","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib251","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1255\/ejms.1083","article-title":"Characterization of oxidized phosphatidylethanolamine derived from RAW 264.7 cells using 4-(dimethylamino)benzoic acid derivatives","volume":"16","author":"Zemski Berry","year":"2010","journal-title":"Eur. J. Mass Spectrom."},{"issue":"Suppl 1","key":"10.1016\/j.redox.2019.101119_bib252","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/10715762.2013.792926","article-title":"Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products","volume":"47","author":"Aldini","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2019.101119_bib253","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0306-3623(97)00300-5","article-title":"Antioxidant and pharmacodynamic effects of pyridoindole stobadine","volume":"30","author":"Horakova","year":"1998","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.redox.2019.101119_bib254","first-page":"56","article-title":"Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: comparison with vitamin E and BHT","volume":"11","author":"Kyselova","year":"2005","journal-title":"Mol. Vis."},{"key":"10.1016\/j.redox.2019.101119_bib255","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/0006-2952(96)00033-0","article-title":"Effect of stobadine on Cu(++)-mediated oxidation of low-density lipoprotein","volume":"51","author":"Horakova","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2019.101119_bib256","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0925-4439(02)00141-2","article-title":"In vivo treatment with stobadine prevents lipid peroxidation, protein glycation and calcium overload but does not ameliorate Ca2+ -ATPase activity in heart and liver of streptozotocin-diabetic rats: comparison with vitamin E","volume":"1588","author":"Pekiner","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2019.101119_bib257","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/tx00027a006","article-title":"Antioxidant activity of the pyridoindole stobadine. Pulse radiolytic characterization of one-electron-oxidized stobadine and quenching of singlet molecular oxygen","volume":"5","author":"Steenken","year":"1992","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.redox.2019.101119_bib258","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/db11-1120","article-title":"Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications","volume":"61","author":"Nagai","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2019.101119_bib259","doi-asserted-by":"crossref","first-page":"48967","DOI":"10.1074\/jbc.M108196200","article-title":"Chelating activity of advanced glycation end-product inhibitors","volume":"276","author":"Price","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib260","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2174\/138920006779010601","article-title":"Endogenous glutathione adducts","volume":"7","author":"Blair","year":"2006","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.redox.2019.101119_bib261","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/10715762.2018.1468564","article-title":"N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why","volume":"52","author":"Aldini","year":"2018","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2019.101119_bib262","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/biof.5520240134","article-title":"HNE-dependent molecular damage in diabetic nephropathy and its possible prevention by N-acetyl-cysteine and oxerutin","volume":"24","author":"Furfaro","year":"2005","journal-title":"Biofactors"},{"key":"10.1016\/j.redox.2019.101119_bib263","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0735-1097(02)01797-7","article-title":"N-acetylcysteine in acute cardiology: 10 years later: what do we know and what would we like to know?!","volume":"39","author":"Sochman","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.redox.2019.101119_bib264","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40256-018-0275-2","article-title":"A systematic review on the protective effect of N-acetyl cysteine against diabetes-associated cardiovascular complications","volume":"18","author":"Dludla","year":"2018","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.redox.2019.101119_bib265","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1159\/000486115","article-title":"N-acetylcysteine influence on oxidative stress and cardiac remodeling in rats during transition from compensated left ventricular hypertrophy to heart failure","volume":"44","author":"Reyes","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.redox.2019.101119_bib266","article-title":"N-acetylcysteine attenuates the development of cardiac fibrosis and remodeling in a mouse model of heart failure","volume":"4","author":"Giam","year":"2016","journal-title":"Phys. Rep."},{"key":"10.1016\/j.redox.2019.101119_bib267","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCRESAHA.108.183749","article-title":"Oxidized low-density lipoproteins trigger endoplasmic reticulum stress in vascular cells: prevention by oxygen-regulated protein 150 expression","volume":"104","author":"Sanson","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2019.101119_bib268","doi-asserted-by":"crossref","first-page":"16339","DOI":"10.1038\/srep16339","article-title":"N-acetylcysteine inhibits in vivo oxidation of native low-density lipoprotein","volume":"5","author":"Cui","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2019.101119_bib269","doi-asserted-by":"crossref","first-page":"998","DOI":"10.5551\/jat.8870","article-title":"The antioxidant N-acetylcysteine promotes atherosclerotic plaque stabilization through suppression of RAGE, MMPs and NF-kappaB in ApoE-deficient mice","volume":"18","author":"Lu","year":"2011","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.redox.2019.101119_bib270","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1089\/ars.2010.3321","article-title":"Antiatherogenic effect of bisvanillyl-hydralazone, a new hydralazine derivative with antioxidant, carbonyl scavenger, and antiapoptotic properties","volume":"14","author":"Bouguerne","year":"2011","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2019.101119_bib271","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.freeradbiomed.2008.08.026","article-title":"Carbonyl scavenger and antiatherogenic effects of hydrazine derivatives","volume":"45","author":"Galvani","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib272","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.RES.0000216288.93234.c3","article-title":"Desensitization of platelet-derived growth factor receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions: prevention by aldehyde scavengers","volume":"98","author":"Vindis","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2019.101119_bib273","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1073\/pnas.89.15.6876","article-title":"Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors","volume":"89","author":"Picard","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2019.101119_bib274","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00726-005-0209-6","article-title":"Reaction of pyridoxamine with malondialdehyde: mechanism of inhibition of formation of advanced lipoxidation end-products","volume":"30","author":"Kang","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.redox.2019.101119_bib275","doi-asserted-by":"crossref","first-page":"21177","DOI":"10.1074\/jbc.M003263200","article-title":"Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine","volume":"275","author":"Onorato","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib276","doi-asserted-by":"crossref","first-page":"42012","DOI":"10.1074\/jbc.M304292200","article-title":"Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of protein and development of diabetic complications","volume":"278","author":"Metz","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib277","article-title":"Inhibition effect of pyridoxamine on lipid hydroperoxide-derived modifications to human serum albumin","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2019.101119_bib278","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.bcp.2003.07.004","article-title":"Involvement of advanced lipooxidation end products (ALEs) and protein oxidation in the apoptotic actions of nitric oxide in insulin secreting RINm5F cells","volume":"66","author":"Cahuana","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2019.101119_bib279","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1046\/j.1523-1755.2002.00207.x","article-title":"Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat","volume":"61","author":"Degenhardt","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.redox.2019.101119_bib280","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s00018-005-5082-7","article-title":"Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage","volume":"62","author":"Voziyan","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.redox.2019.101119_bib281","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1152\/physrev.00039.2012","article-title":"Physiology and pathophysiology of carnosine","volume":"93","author":"Boldyrev","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.redox.2019.101119_bib282","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1043-4526(09)57003-9","article-title":"Carnosine and its possible roles in nutrition and health","volume":"57","author":"Hipkiss","year":"2009","journal-title":"Adv. Food Nutr. Res."},{"key":"10.1016\/j.redox.2019.101119_bib283","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1021\/jf980780j","article-title":"Ability of carnosine and other skeletal muscle components to quench unsaturated aldehydic lipid oxidation products","volume":"47","author":"Zhou","year":"1999","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.redox.2019.101119_bib284","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jms.517","article-title":"Acrolein-sequestering ability of endogenous dipeptides: characterization of carnosine and homocarnosine\/acrolein adducts by electrospray ionization tandem mass spectrometry","volume":"38","author":"Carini","year":"2003","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.redox.2019.101119_bib285","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbrc.2017.08.069","article-title":"Quenching activity of carnosine derivatives towards reactive carbonyl species: focus on alpha-(methylglyoxal) and beta-(malondialdehyde) dicarbonyls","volume":"492","author":"Vistoli","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2019.101119_bib286","doi-asserted-by":"crossref","first-page":"9174","DOI":"10.1021\/ac7016184","article-title":"HNE Michael adducts to histidine and histidine-containing peptides as biomarkers of lipid-derived carbonyl stress in urines: LC-MS\/MS profiling in Zucker obese rats","volume":"79","author":"Orioli","year":"2007","journal-title":"Anal. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib287","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1172\/JCI94307","article-title":"A carnosine analog mitigates metabolic disorders of obesity by reducing carbonyl stress","volume":"128","author":"Anderson","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2019.101119_bib288","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2012.01834.x","article-title":"D-Carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation","volume":"166","author":"Menini","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2019.101119_bib289","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0098-2997(03)00014-1","article-title":"The proteasomal system and HNE-modified proteins","volume":"24","author":"Grune","year":"2003","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.redox.2019.101119_bib290","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1194\/jlr.M053256","article-title":"Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine","volume":"55","author":"Gonen","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.redox.2019.101119_bib291","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.redox.2013.07.006","article-title":"Biological markers of oxidative stress: applications to cardiovascular research and practice","volume":"1","author":"Ho","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2019.101119_bib292","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1161\/RES.0000000000000110","article-title":"Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system: a scientific statement from the American heart association","volume":"119","author":"Griendling","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2019.101119_bib293","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6501046","article-title":"Measurement and clinical significance of biomarkers of oxidative stress in humans","volume":"2017","author":"Marrocco","year":"2017","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.redox.2019.101119_bib294","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jacc.2007.11.051","article-title":"Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the PREVENT study","volume":"51","author":"Walter","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.redox.2019.101119_bib295","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.redox.2013.12.009","article-title":"Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure","volume":"2","author":"Asselin","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2019.101119_bib296","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/eurheartj\/ehm071","article-title":"Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect","volume":"28","author":"Belardinelli","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.redox.2019.101119_bib297","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2143\/AC.63.4.2033038","article-title":"Urinary 8-isoprostane levels can indicate the presence, severity and extent of angiographic coronary artery disease","volume":"63","author":"Basarici","year":"2008","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.redox.2019.101119_bib298","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.atherosclerosis.2005.05.008","article-title":"Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease","volume":"184","author":"Wang","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.redox.2019.101119_bib299","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.freeradbiomed.2006.09.001","article-title":"Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease","volume":"41","author":"Shishehbor","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib300","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/ajcn\/88.3.630","article-title":"Lipoprotein-associated phospholipase A2 activity is associated with coronary artery disease and markers of oxidative stress: a case-control study","volume":"88","author":"Kim","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.redox.2019.101119_bib301","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-60761-411-1_14","article-title":"OXY-SCORE: a global index to improve evaluation of oxidative stress by combining pro- and antioxidant markers","volume":"594","author":"Veglia","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.redox.2019.101119_bib302","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-60327-517-0_3","article-title":"An easy and reliable automated method to estimate oxidative stress in the clinical setting","volume":"477","author":"Vassalle","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.redox.2019.101119_bib303","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/13547500600898623","article-title":"Age- and gender-related oxidative status determined in healthy subjects by means of OXY-SCORE, a potential new comprehensive index","volume":"11","author":"Veglia","year":"2006","journal-title":"Biomarkers"},{"key":"10.1016\/j.redox.2019.101119_bib304","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/abio.1999.4073","article-title":"A 1-hour enzyme-linked immunosorbent assay for quantitation of acrolein- and hydroxynonenal-modified proteins by epitope-bound casein matrix method","volume":"270","author":"Satoh","year":"1999","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.redox.2019.101119_bib305","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jms.1890","article-title":"A mass spectrometric analysis of 4-hydroxy-2-(E)-nonenal modification of cytochrome c","volume":"46","author":"Tang","year":"2011","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.redox.2019.101119_bib306","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.healun.2004.02.021","article-title":"Formation of 4-hydroxy-2-nonenal protein adducts in the ischemic rat heart after transplantation","volume":"24","author":"Renner","year":"2005","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.redox.2019.101119_bib307","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/eurheartj\/ehq253","article-title":"Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia\/reperfusion injury: role of autophagy paradox and toxic aldehyde","volume":"32","author":"Ma","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.redox.2019.101119_bib308","first-page":"2054","article-title":"Overexpression of heart-type fatty acid binding protein enhances fatty acid-induced podocyte injury","volume":"15","author":"Gao","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.redox.2019.101119_bib309","doi-asserted-by":"crossref","first-page":"42400","DOI":"10.1074\/jbc.M112.385831","article-title":"Post-translational modification of serine\/threonine kinase LKB1 via Adduction of the Reactive Lipid Species 4-Hydroxy-trans-2-nonenal (HNE) at lysine residue 97 directly inhibits kinase activity","volume":"287","author":"Calamaras","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib310","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.redox.2018.08.018","article-title":"Suppression of hERG K(+) current and cardiac action potential prolongation by 4-hydroxynonenal via dual mechanisms","volume":"19","author":"Choi","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2019.101119_bib311","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.jacc.2004.08.029","article-title":"Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study","volume":"44","author":"Walter","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.redox.2019.101119_bib312","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1042\/CS20050317","article-title":"Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support","volume":"110","author":"White","year":"2006","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.redox.2019.101119_bib313","doi-asserted-by":"crossref","first-page":"18473","DOI":"10.1074\/jbc.M110.118182","article-title":"Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway","volume":"285","author":"Shao","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101119_bib314","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbrc.2005.02.135","article-title":"Aconitase and ATP synthase are targets of malondialdehyde modification and undergo an age-related decrease in activity in mouse heart mitochondria","volume":"330","author":"Yarian","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2019.101119_bib315","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/pmic.200700111","article-title":"Analysis of modified apolipoprotein B-100 structures formed in oxidized low-density lipoprotein using LC-MS\/MS","volume":"7","author":"Obama","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.redox.2019.101119_bib316","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1161\/01.ATV.17.11.3236","article-title":"Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions","volume":"17","author":"Gniwotta","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.redox.2019.101119_bib317","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/01.CIR.0000116761.93647.30","article-title":"Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study","volume":"109","author":"Schwedhelm","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2019.101119_bib318","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.plefa.2008.03.001","article-title":"Increased isoprostane content in coronary plaques obtained from vulnerable patients","volume":"78","author":"Nishibe","year":"2008","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.redox.2019.101119_bib319","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.freeradbiomed.2010.11.023","article-title":"F2-isoprostanes as an indicator and risk factor for coronary heart disease","volume":"50","author":"Davies","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101119_bib320","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjcard.2009.04.047","article-title":"Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome","volume":"104","author":"LeLeiko","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.redox.2019.101119_bib321","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1538-7836.2003.00072.x","article-title":"Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus","volume":"1","author":"De Cristofaro","year":"2003","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.redox.2019.101119_bib322","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1111\/bph.12677","article-title":"Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation","volume":"171","author":"Bauer","year":"2014","journal-title":"Br. J. Pharmacol."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231718308863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231718308863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:09:31Z","timestamp":1761977371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231718308863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":322,"alternative-id":["S2213231718308863"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2019.101119","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoxidation in cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2019.101119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101119"}}